Expertise in
1
conditions

Maria A. Fabbri

Viterbo, IT 
Expertise in
1
conditions
Viterbo, IT 

Overview

Maria Fabbri practices practicing medicine in Viterbo, Italy.

Ms. Fabbri is highly rated in 1 condition, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Breast Cancer, Metastatic Brain Tumor, and Triple-Negative Breast Cancer.

She is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Viterbo, 01100, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

postMONARCH: A Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy of Abemaciclib Plus Fulvestrant to Placebo Plus Fulvestrant in Participants With HR+, HER2-, Advanced or Metastatic Breast Cancer Following Progression on a CDK4 & 6 Inhibitor and Endocrine Therapy
postMONARCH: A Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy of Abemaciclib Plus Fulvestrant to Placebo Plus Fulvestrant in Participants With HR+, HER2-, Advanced or Metastatic Breast Cancer Following Progression on a CDK4 & 6 Inhibitor and Endocrine Therapy
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3

27 Total Publications

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 14, 2026

Frequently Asked Questions about Maria A. Fabbri

Is Maria A. Fabbri a top-rated expert for HER-2 Positive Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Maria A. Fabbri is classified as an Distinguished expert for HER-2 Positive Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Maria A. Fabbri participate in research or clinical trials?

Yes. Maria A. Fabbri has published 27 articles and abstracts on conditions like HER-2 Positive Breast Cancer. You can view a list of Maria A. Fabbri's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Fabbri's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile